Kyverna Therapeutics, Inc. Quarterly Operating Lease, Liability in USD from Q1 2024 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Present value of lessee's discounted obligation for lease payments from operating lease.
Summary
Kyverna Therapeutics, Inc. quarterly Operating Lease, Liability history and growth rate from Q1 2024 to Q3 2024.
  • Kyverna Therapeutics, Inc. Operating Lease, Liability for the quarter ending September 30, 2024 was $7.97M.
Operating Lease, Liability, Quarterly (USD)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $7.97M Sep 30, 2024 10-Q 2024-11-13
Q2 2024 $8.59M Jun 30, 2024 10-Q 2024-08-12
Q1 2024 $9.2M Mar 31, 2024 10-Q 2024-05-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.